Welcome to our dedicated page for Tian'an Technology Group SEC filings (Ticker: TANAF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Tian'an Technology Group's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Tian'an Technology Group's regulatory disclosures and financial reporting.
Tian’an Technology Group Ltd (TANAF) reported unaudited results for the six months ended June 30, 2026. Total revenue was $433,784, compared with $471,198 in the same period of 2025, all primarily from sales of intelligent graphene moxibustion devices in the PRC.
Gross profit declined to $116,846 from $162,878, and the company moved from operating income of $20,628 to an operating loss of $6,784. Net results swung from net income of $20,115 to a net loss of $7,876, with comprehensive loss of $9,868 after foreign currency translation effects.
Total assets dropped sharply to $167,401 from $583,873, largely as advances to suppliers fell from $507,725 to $21,461. Due to related parties decreased from $537,724 to $196,268 following substantial repayments. Cash, cash equivalents and restricted cash increased to $145,940, while stockholders’ equity remained negative, with a deficit widening to $(81,643).
Tian’an Technology Group Ltd., a British Virgin Islands holding company operating in China through subsidiaries, has registered 10,000,000 Ordinary Shares for resale by existing investors. These shares were previously issued in a private placement at $3.70 per share, and Tian’an will receive no proceeds from their resale.
The group’s operating business is conducted by Shanghai Qige and Henan Qige in China, selling graphene-based far‑infrared health therapy products such as energy rooms, heating blankets, pillows, and knee pads. Ordinary Shares represent equity in the BVI holding company, not direct ownership of the Chinese entities.
The company highlights extensive PRC legal, regulatory, capital‑control and HFCA Act risks that could limit cash transfers, affect overseas listings, or even render the shares worthless. For 2025, Tian’an reported $734,893 in revenue and a net loss of $89,931, with negative shareholders’ equity and no history or current intention of paying dividends. It intends to seek quotation of its shares on the OTCQB, but there is currently no public market.
Tian’an Technology Group Ltd. amends a Form F-1 registration to register for resale 10,000,000 Ordinary Shares previously issued in a private placement at $3.70 per share. The shares are being registered on behalf of the Selling Shareholders; the company will receive no proceeds from these resales.
The prospectus describes Tian’an as a BVI holding company whose operating activities are conducted through PRC subsidiaries, principally Shanghai Qige. Financial highlights show Revenues $734,893 and Net loss $(89,931) for year ended December 31, 2025, and Revenues $1,783,130 and Net income $454,590 for year ended December 31, 2024. The registration relates only to resale by existing holders; the company intends to seek OTC quotation but currently has no market maker.
Tian’an Technology Group Ltd., a British Virgin Islands holding company with operations in China through subsidiaries including Shanghai Qige, filed its annual report for the year ended December 31, 2025. The company had 45,518,000 Ordinary Shares outstanding as of that date.
The report emphasizes that Tian’an is an emerging growth company and details extensive risk factors tied to product quality, customer concentration, competition, cybersecurity, product liability, and reliance on key personnel. It also outlines significant legal and regulatory risks from operating in China, including foreign investment limits, possible treatment of variable interest entity structures, currency controls, exchange-rate volatility, tax uncertainty, and evolving data and cybersecurity rules.
Tian’an Technology Group Ltd. filed a Form F-1 registering for resale 10,000,000 Ordinary Shares previously issued in a private placement at a purchase price of $3.70 per share. The registration is for resale by the selling shareholders; the company will not receive proceeds from those resales.
The company is a BVI holding company that conducts operations through PRC subsidiaries (Shanghai Qige and Henan Qige). Fiscal 2024 results show revenues $1,783,130 and net income $454,590. The prospectus highlights regulatory, dividend repatriation, and PRC oversight risks, and states intent to seek quotation on the OTCQB/OTCQX.